Private Equity
Latest news, explainers and analysis on Private Equity. Tracking 21 stories on Arth Vani.
Connected in the graph
Latest on Private Equity
BreakingAlpha Wave Ventures Sells ₹1,857 Crore Stake in Lenskart Via Block Deals
Alpha Wave Ventures, an early investor in the prominent eyewear retailer Lenskart, has sold 2.94 crore shares valued at ₹1,857 crore through block deals. This significant transaction marks a continued trend of initial backers diluting their stake in the growing Indian startup.
RQD* Clearing Secures ₹617 Crore ($74M) Investment Led by Bain Capital
RQD* Clearing, a US-based technology firm focused on clearing and custody services, has raised $74 million (approximately ₹617 crore) in a minority growth investment. The funding round was led by global private equity giant Bain Capital. This investment aims to fuel the company's expansion in the financial services sector.
SpaceX: Unpacking the 'Boom or Bust' Debate for Elon Musk's Private Venture
This report explores the ongoing valuation debate surrounding Elon Musk's privately held aerospace company, SpaceX, which is currently not available for direct public investment by retail investors in India or globally. Discussions about SpaceX's financial health and future prospects often highlight its potential for innovation versus its significant capital expenditure needs.
BreakingParliamentary Panel Proposes Cap on Private Hospital Room Charges at 3-Star Hotel Rates
A parliamentary committee has recommended capping private hospital room rents to match three-star hotel rates to improve healthcare affordability. The proposal comes amid rising private equity investments in the healthcare sector that have driven up valuations and treatment costs.
SpaceX Valuation Forecast: Report Suggests $220 Target by June 2027
A global financial report from Yahoo Finance has suggested that aerospace firm SpaceX could see its valuation reach $220 by June 2027. The original report's title also contained a promotional phrase about investment timing, but no detailed analysis or underlying data was available in the provided source material.
Morgan Stanley Boosts Conviction in SpaceX Stock
Global financial services firm Morgan Stanley has reportedly 'doubled down' on its investment or conviction in Elon Musk's private space company, SpaceX. This move signals heightened institutional confidence in the aerospace and satellite internet pioneer, though direct retail investment remains largely inaccessible.
Nvidia Invests ₹1.75 Lakh Crore in SpaceX via xAI by Q2 End
Nvidia has disclosed a substantial ₹1.75 lakh crore ($21 billion) stake in Elon Musk's aerospace company, SpaceX, as of the end of the second quarter. This significant investment was made indirectly through its participation in xAI, another venture founded by Musk. The move highlights Nvidia's strategic interest in diversifying into cutting-edge high-tech sectors.
New LaunchBreakingAccel Launches $550 Million India Fund, Targets AI & Fintech Startups
Venture capital firm Accel has announced a new $550 million India fund, part of a larger $3.5 billion global fundraise. This fund will primarily focus on investing in Indian startups across AI, fintech, and advanced manufacturing sectors.
IPOPaine Schwartz Partners to Boost Stake in Suja Life via Open-Market Purchases
Paine Schwartz Partners (PSP), a private equity firm, announced on August 4, 2026, its intention to increase its ownership in Suja Life through open-market share purchases. This move follows PSP's decision not to sell any shares during Suja Life's initial public offering.
IPOBreakingWhy Consumer Brands are Shunning IPOs to Stay Private Longer
A shift in global financial trends shows consumer-facing companies are increasingly avoiding public listings in favor of secondary markets. This trend, driven by high liquidity in private sectors, allows firms to scale without the regulatory pressures of a stock market debut.
ChrysCapital Takes Controlling Stake in Novartis India; New CEO Appointed
Indian private equity firm ChrysCapital has acquired a controlling stake in Novartis India Limited, marking its first majority-controlled investment in the country's pharmaceutical sector. As part of this significant development, a new Chief Executive Officer has been appointed to lead Novartis India.
SpaceX Valuation Plummets Over $1.2 Trillion (₹100 Lakh Cr) Since June Peak
Elon Musk's private space company, SpaceX, has reportedly experienced a massive drop in its market capitalization, falling by over $1.2 trillion (approximately ₹100 lakh crore). This significant decline occurred since its share price reached a high of $225.64 (around ₹18,700) in June, marking a substantial shift in its private valuation.
Quadria Capital Plans Major Exits via Maxivision and Aragen IPOs by 2027
Healthcare-focused private equity firm Quadria Capital is targeting 1.5x cash returns for its investors by early 2027. The firm plans to achieve this through public listings of portfolio companies like Maxivision Eye Hospital and Aragen Life Sciences.
Partners Group Closes ₹45,650 Crore Infra Fund, Focuses on Value Creation
Global investment firm Partners Group has successfully closed its latest infrastructure secondaries fund, raising approximately ₹45,650 crore (USD 5.5 billion). The fund's strategy emphasizes actively creating value from existing infrastructure assets rather than solely relying on discounted purchases.
IPOSpaceX Seeks Pentagon Boost After Post-IPO Valuation Drop
SpaceX is reportedly turning to the US Pentagon for new contracts to help stabilize and increase the value of its stock, referred to as SPCX. This strategic move follows a significant decline in its valuation after what has been described as a 'post-IPO selloff' in private markets. The aerospace firm aims to leverage government contracts to rebound from the recent drop.
Indian Biotech Sector Booms as Startup Count Hits 2,400; PE Investments Double
India's pharmaceutical and biotech landscape is witnessing a massive shift with private equity investments doubling to $731 million. A new report highlights that the number of biotech startups has surged to 2,400, signaling a robust pipeline for new drug development.
SpaceX Shares: What Indian Investors Should Know About Private Market Holdings
While SpaceX is a prominent global company, its shares are not publicly traded on stock exchanges. Indian investors holding private SpaceX shares need to understand the nuances of such investments, including liquidity challenges and valuation complexities.
Wealthy Indians Eye Direct Alternative Investments, Bypassing Traditional Funds
High-net-worth individuals in India are increasingly seeking direct access to alternative investments like private equity and real estate, moving away from traditional fund structures. This shift is driven by a desire for greater control, potentially higher returns, and lower fees, as they look to diversify beyond conventional stocks and bonds.
Sebi Eases Exit Rules for AIFs: Funds Can Now Retain Assets Beyond Expiry
Market regulator Sebi has introduced new guidelines allowing Alternative Investment Funds (AIFs) to manage and retain liquidation proceeds even after their formal tenure ends. This move aims to prevent distressed sales and ensure better returns for high-net-worth investors.
Carlyle Prepares to Launch Healthcare Services IPO in India
Global private equity firm Carlyle is eyeing a public listing for its healthcare revenue cycle management platform. The company, formed by merging Knack RCM and EqualizeRCM, is currently in the process of selecting investment banks to manage the debut.
Kotak Mutual Fund Invests ₹612 Crore in Emcure Pharma; PE Firm BC Investments Exits
Private equity firm BC Investments IV has sold its stake in Emcure Pharmaceuticals to Kotak Mutual Fund for ₹612 crore. This major transaction highlights growing institutional confidence in Emcure's growth potential across key medical segments.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.